Carocell Bio are developing novel anti-inflammatory peptides to more safely treat inflammatory diseases. Our lead (JEL3108) is to more safely treat atopic dermatitis (AD, eczema), prevent its recurrence and possibly delay ageing of the skin.
London BioScience Innovation Centre
2 Royal College Street
London
NW1 0NH
United Kingdom
Tel: +44 (0) 20 7691 1122